MSB 2.17% $1.13 mesoblast limited

Ann: Submits New Information to FDA IND File for SR-aGVHD, page-44

  1. 15,487 Posts.
    lightbulb Created with Sketch. 5576
    LMAO .... Pot Kettle by the looks re: education and profits as you seem have no idea what doors an FDA approval for Remestemcel-L would open up for the company through label extensions; or what the price of the treatment is; etc etc but hey I am not going to waste my time educating you ...


    ..... enjoy your day hating on the company that is trying to make a difference by treating patients with this devastating disease of SR-aGVHD where survival outcomes have not improved in the past two decades


    upload_2022-10-3_11-18-34.png


    As for your comments re: instos .... they are also incorrect .... your lack of research on posters on the very forum you are today criticising don't seem to recognise that more than a few people on here sold chunks in the $5's in 2020 so the company owes us nothing but you are happy to make patronising comments and assumptions that only the instos did that .... the below post is an example of a non insto selling in 2020 - just sayin'


    https://hotcopper.com.au/threads/ba...10558/page-2645?post_id=54560930#.Yzorb3ZBzIV
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.